Q-linea AB's total inventories for the quarter that ended in Mar. 2026 was kr29.80 Mil. Q-linea AB's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was kr30.24 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Q-linea AB's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was kr11.19.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Q-linea AB's Days Inventory for the
three
months ended in Mar. 2026 was 2,162.47.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Q-linea AB's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Q-linea AB's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 14.93.
Q-linea AB (OSTO:QLINEA) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Q-linea AB's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Q-linea AB's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Q-linea AB Total Inventories Related Terms
Q-linea AB Total Inventories Historical Data
* Premium members only.
The historical data trend for Q-linea AB's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of kr29.80 Mil mean?
Q-linea AB (OSTO:QLINEA) has a Total Inventories of kr29.80 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Q-linea AB and its competitors.
Is Q-linea AB's Total Inventories too high?
Q-linea AB's current Total Inventories is kr29.80 Mil. Overall, Q-linea AB has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Total Inventories compare to ABT and SYK?
Q-linea AB's Total Inventories of kr29.80 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Q-linea AB and its competitors. Q-linea AB's current Total Inventories is kr29.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Based on GuruFocus' analysis, Q-linea AB (OSTO:QLINEA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr19.86, compared to a current price of kr17.60 — trading 11.4% below its estimated fair value. The current Total Inventories is kr29.80 Mil. Q-linea AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Q-linea AB (OSTO:QLINEA), the current Total Inventories is kr29.80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Q-linea AB (OSTO:QLINEA) Overvalued in 2026?
Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued.
The current stock price of kr17.60 is trading 11.4% below its estimated GF Value™ of kr19.86.
GuruFocus considers Q-linea AB to be Modestly Undervalued.
Key valuation signals for OSTO:QLINEA:
Total Inventories: kr29.80 Mil
GF Value™: kr19.86 vs. price of kr17.60 (11.4% below fair value)
No single metric tells the full story. See the OSTO:QLINEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
67GF Score
Get the complete analysis for OSTO:QLINEA
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLINEA has been successfully added to your 
